Dr. Michael R. Laffer, D.O.
Pulmonology (Pulmonary Disease Physician)
- Medicare participating
At a glance
- Medical school
- Des Moines University of Osteopathic Medicine and Health Sciences (1975)
- Years since graduation
- 51
- In the NPI registry since
- 2005
- Medicare patients seen, 2024
- 552
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1975Medical school: Des Moines University of Osteopathic Medicine and Health Sciences
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Pulmonary Disease Physician primary
MI license 5101006980
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Beaumont Hospital Royal Oak Royal Oak, MI
- Beaumont Hospital - Farmington Hills Farmington Hills, MI
- Ascension Providence Hospital, Southfield and Novi Southfield, MI
Medical groups
- Michigan Healthcare Professionals PC (529 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 552
- Services billed
- 1,786
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 669 | 350 |
| Established patient office or other outpatient visit, 20-29 minutes | 237 | 163 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 225 | 222 |
| Test to determine lung volumes using sensors | 225 | 222 |
| Test to examine how well the lungs exchange gases | 224 | 221 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 170 | 94 |
| New patient office or other outpatient visit, 45-59 minutes | 96 | 96 |
| Evaluation of use of breathing device | 87 | 68 |
| Telephone medical discussion with physician, 11-20 minutes | 26 | 20 |
| Test for exercise-induced lung stress | 24 | 22 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Trelegy Ellipta (fluticasone/umeclidin/vilanter) Other prescribers in Farmington Hills, MI | 836 |
| Albuterol Sulfate Hfa (albuterol sulfate) Other prescribers in Farmington Hills, MI | 772 |
| Stiolto Respimat (tiotropium br/olodaterol hcl) Other prescribers in Farmington Hills, MI | 196 |
| Breztri Aerosphere (budesonide/glycopyr/formoterol) Other prescribers in Farmington Hills, MI | 180 |
| Ventolin Hfa (albuterol sulfate) Other prescribers in Farmington Hills, MI | 153 |
| Montelukast Sodium Other prescribers in Farmington Hills, MI | 149 |
| Fluticasone Propionate Other prescribers in Farmington Hills, MI | 146 |
| Prednisone Other prescribers in Farmington Hills, MI | 137 |
| Spiriva Respimat (tiotropium bromide) Other prescribers in Farmington Hills, MI | 134 |
| Anoro Ellipta (umeclidinium brm/vilanterol tr) Other prescribers in Farmington Hills, MI | 114 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 20 companies reported 64 payments worth $1,337 in total to this clinician.
| AstraZeneca Pharmaceuticals LP | $393 |
|---|---|
| GlaxoSmithKline, LLC. | $289 |
| Genzyme Corporation | $182 |
| Regeneron Healthcare Solutions, Inc. | $59.60 |
| Pulmonx Corporation | $54.49 |
| Actelion Pharmaceuticals US, Inc. | $52.52 |
| Merck Sharp & Dohme LLC | $42.17 |
| Takeda Pharmaceuticals U.S.A., Inc. | $34.67 |
| Food and Beverage | $1,337 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.